The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has ยฃ9.06 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | ยฃ9.54 B | 11.07% |
2023-12-31 | ยฃ8.59 B | 11.69% |
2022-12-31 | ยฃ7.69 B | 29.18% |
2021-12-31 | ยฃ5.95 B | -23.77% |
2020-12-31 | ยฃ7.81 B | 14.94% |
2019-12-31 | ยฃ6.79 B | -70.56% |
2018-12-31 | ยฃ23.08 B | -25.14% |
2017-12-31 | ยฃ30.83 B | -0.09% |
2016-12-31 | ยฃ30.86 B | 45.75% |
2015-12-31 | ยฃ21.17 B | 21.99% |
2014-12-31 | ยฃ17.35 B | 47.59% |
2013-12-31 | ยฃ11.76 B | -20.99% |
2012-12-31 | ยฃ14.88 B | 12.1% |
2011-12-31 | ยฃ13.28 B | 17.67% |
2010-12-31 | ยฃ11.28 B | 35.86% |
2009-12-31 | ยฃ8.30 B | 27.45% |
2008-12-31 | ยฃ6.51 B | 81.06% |
2007-12-31 | ยฃ3.59 B | 12.33% |
2006-12-31 | ยฃ3.20 B | 5.16% |
2005-12-31 | ยฃ3.04 B | 0.73% |
2004-12-31 | ยฃ3.02 B | 5.64% |
2003-12-31 | ยฃ2.86 B | -1.54% |
2002-12-31 | ยฃ2.90 B | 58.42% |
2001-12-31 | ยฃ1.83 B | 35.12% |
2000-12-31 | ยฃ1.35 B | 64.72% |
1999-12-31 | ยฃ0.82 B | 582.13% |
1998-12-31 | ยฃ0.12 B | -16.91% |
1997-12-31 | ยฃ0.14 B | 47.21% |
1996-12-31 | ยฃ98.87 M |